24 participants
A Phase 1 Study of OTS-412 (Recombinant Oncolytic Vaccinia Virus) in Treatment-refractory Solid Tumor Patients
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-08-26
- Start Date:
- 2027-01-31
- Completion:
- 2028-12-31
Conditions
- Treatment-Refractory Solid Tumors
Interventions
- DRUG
No Results Yet